These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5804822)

  • 1. [Cardiovascular disorders in the course of antimitotic infusions at high doses. 30 clinical cases].
    Gaveau T; Banzet P; Marneffe H; Viars P
    Anesth Analg (Paris); 1969; 26(3):311-27. PubMed ID: 5804822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of inoperable tumors by continuous and prolonged arterial perfusion of an antimitotic association].
    Nervi C; Casale C; Cortese M
    Presse Med (1893); 1969 Nov; 77(51):1904. PubMed ID: 4189112
    [No Abstract]   [Full Text] [Related]  

  • 3. [The state of the cardiovascular system during long-term perfusion chemotherapy of cancer of the mammary glands].
    Orlova PN; Gol'dman BG
    Vopr Onkol; 1969; 15(2):18-22. PubMed ID: 4977802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Skin manifestations of prolonged intra-arterial perfusions of antimitotic agents].
    Magendie J; Périssat J
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(1):94-7. PubMed ID: 5942312
    [No Abstract]   [Full Text] [Related]  

  • 5. [Side effects of cytotoxic drugs on the nervous system].
    Mintz U; Kuritzky A
    Harefuah; 1976 Nov; 91(9):294-7. PubMed ID: 795752
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
    Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
    Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in nail pigment after chemotherapy.
    Daoud D; Fox N; Tan J
    Arch Intern Med; 1977 Sep; 137(9):1259. PubMed ID: 901099
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular toxicity of anticancer chemotherapy: 5 cases treated in intensive care].
    Sotiriou C; Sculier JP
    Rev Med Brux; 1995; 16(2):65-7. PubMed ID: 7784738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A portable pump ("conjector") for regional perfusion cancer chemotherapy.
    Barkin M; Cowan CR; MacDonald JA; Mahoney LJ
    Can Med Assoc J; 1966 Nov; 95(21):1087-9. PubMed ID: 5297053
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vascular isolation and perfusion of the liver in clinical practice].
    Granov AM; Borisov AE; Plotkin LL; Zemlianoĭ VP; Shelukhin AP
    Vestn Khir Im I I Grek; 1982 Apr; 128(4):44-8. PubMed ID: 7101639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The results of attack polychemotherapy in broncho-pleuro-pulmonary cancer. Phytohemagglutinin in the prevention and treatment of hematologic complications of antimitotics].
    Brocard H; Akoun G
    Poumon Coeur; 1968; 24(1):33-8. PubMed ID: 5652205
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of lithium carbonate in mastectomized patients undergoing cancer therapy].
    Marzetti L; Marcellini G; Midulla C
    Clin Ter; 1982 Nov; 103(4):405-9. PubMed ID: 6817959
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-hematologic adverse effects of cytostatic drugs].
    Singer Z; Kozaczka A; Wilk J; Janas J
    Pol Tyg Lek; 1984 Nov; 39(47):1535-41. PubMed ID: 6240028
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebral ischemic events and anti-cancer therapy].
    El Amrani M; Aidi S; Amarenco P
    Rev Neurol (Paris); 2003 Apr; 159(4):371-80. PubMed ID: 12773866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer.
    Tsuchiya N; Inoue T; Narita S; Kumazawa T; Saito M; Obara T; Tsuruta H; Horikawa Y; Yuasa T; Satoh S; Habuchi T
    J Urol; 2008 Dec; 180(6):2389-95. PubMed ID: 18930278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.